Ipamorelin Clinical Trials: Results & How to Enroll
Complete guide to Ipamorelin clinical trial history, published results, and current research status.
Clinical Trial History
Ipamorelin reliably stimulates GH secretion in a dose-dependent manner with high selectivity, producing minimal cortisol or prolactin elevations compared to GHRP-6 or GHRP-2.
Ipamorelin accelerated return of gut motility compared to placebo, suggesting utility beyond body composition.
Frequently Asked Questions
What clinical trials have studied Ipamorelin?
Ipamorelin has been studied in multiple clinical trials. The key findings are documented in the clinical research section of this guide. Refer to ClinicalTrials.gov for complete trial records and enrollment information.
Is Ipamorelin still in clinical trials?
No FDA approval. Research use only.. For current trial status, search ClinicalTrials.gov using the drug name "Ipamorelin".
References & Sources
Exploring Retatrutide Access?
See how patients are accessing retatrutide through physician-supervised telehealth and compounding pharmacies.
Not FDA approved. Access requires physician oversight.
Affiliate links — we may earn a commission at no cost to you.